UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion

British journal of cancer, 2013-11, Vol.109 (10), p.2714-2723

2013

Volltextzugriff (PDF)

Chromosomal Imbalances in Barrett's Adenocarcinoma and the Metaplasia-Dysplasia-Carcinoma Sequence

The American journal of pathology, 2000-02, Vol.156 (2), p.555-566

2000

Volltextzugriff (PDF)

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients

British journal of cancer, 2008-10, Vol.99 (7), p.1089-1095

2008

Volltextzugriff (PDF)

Typical and Atypical Carcinoid Tumors of the Lung Are Characterized by 11q Deletions as Detected by Comparative Genomic Hybridization

The American journal of pathology, 1998-10, Vol.153 (4), p.1089-1098

1998

Volltextzugriff (PDF)

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas

British journal of cancer, 2007-03, Vol.96 (5), p.801-807

2007

Volltextzugriff (PDF)

673: uPAR and its interaction partners: potential new therapy targets in triple negative breast cancer

European journal of cancer (1990), 2014-07, Vol.50, p.S161-S162

2014

Volltextzugriff (PDF)

922: Relevance of 3D-microtissues to investigate the therapeutic oncogenes HER2 and PTK6 in breast cancer

European journal of cancer (1990), 2014-07, Vol.50, p.S226-S226

2014

Volltextzugriff (PDF)

Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers

British journal of cancer, 2013-10, Vol.109 (9), p.2347-2355

2013

Volltextzugriff (PDF)

In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues

British journal of cancer, 2010-08, Vol.103 (5), p.663-667

2010

Volltextzugriff (PDF)

Lifetime Study in mice: 24 months follow up after low doses of ionizing radiation with Scheimpflug imaging and OCT

Acta ophthalmologica (Oxford, England), 2016-10, Vol.94 (S256), p.n/a

2016

Volltextzugriff (PDF)

384 Synergistically Reduced Malignancy of Human Breast Cancer Cells Due to Co-Silencing of HER2 and PTK6

European journal of cancer (1990), 2012-11, Vol.48, p.117-117

2012

Volltextzugriff (PDF)

Lifetime study in mice for radiation‐induced cataracts

Acta ophthalmologica (Oxford, England), 2015-10, Vol.93 (S255), p.n/a

2015

Volltextzugriff (PDF)

Abstract P2-05-32: Tissue kallikrein-related peptidase 4, a novel biomarker in triple-negative breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-05-32

2017

Volltextzugriff (PDF)

Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells

Radiation oncology (London, England), 2012-12, Vol.7 (1), p.206-206, Article 206

2012

Volltextzugriff (PDF)

Chromosomal changes during development and progression of prostate adenocarcinomas

British journal of cancer, 2001, Vol.84 (2), p.202-208

2001

Volltextzugriff (PDF)

The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer

Molecular cancer, 2013-04, Vol.12 (1), p.28-28, Article 28

2013

Volltextzugriff (PDF)

Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer

Diagnostic molecular pathology, 2000-03, Vol.9 (1), p.14-19

2000

Volltextzugriff (PDF)

The impact of the uPAR system and its interaction partners as potential therapeutic targets in TNBC

Annals of oncology, 2015-05, Vol.26, p.iii15-iii15

2015

Volltextzugriff (PDF)

PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients

Breast care (Basel, Switzerland), 2021-10, Vol.16 (5), p.523-531

2021

Volltextzugriff (PDF)

Molecular Genetic Changes in Metastatic Primary Barrett's Adenocarcinoma and Related Lymph Node Metastases: Comparison with Nonmetastatic Barrett's Adenocarcinoma

Modern pathology, 2000-07, Vol.13 (7), p.814-824

2000

Volltextzugriff (PDF)

Heterogeneity in breast cancer and the problem of relevance of findings

Analytical cellular pathology, 1999, Vol.19 (2), p.53-58

1999

Volltextzugriff (PDF)

Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis

British journal of cancer, 2000-03, Vol.82 (6), p.1204-1210

2000

Volltextzugriff (PDF)

P3-03-04: Targeted Modulation of HER Receptor Signaling in Breast Cancer Using miR-21

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-03-04

2011

Volltextzugriff (PDF)

Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas

The Journal of pathology, 2005-04, Vol.205 (5), p.592-596

2005

Volltextzugriff (PDF)

Lifetime Study in mice: 24ￂ months follow up after low doses of ionizing radiation with Scheimpflug imaging and OCT

Acta ophthalmologica (Oxford, England), 2016-10, Vol.94 (S256)

2016

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Englisch
(133)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion

Chromosomal Imbalances in Barrett's Adenocarcinoma and the Metaplasia-Dysplasia-Carcinoma Sequence

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients

Typical and Atypical Carcinoid Tumors of the Lung Are Characterized by 11q Deletions as Detected by Comparative Genomic Hybridization

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas

673: uPAR and its interaction partners: potential new therapy targets in triple negative breast cancer

922: Relevance of 3D-microtissues to investigate the therapeutic oncogenes HER2 and PTK6 in breast cancer

Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers

In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues

Lifetime Study in mice: 24 months follow up after low doses of ionizing radiation with Scheimpflug imaging and OCT

384 Synergistically Reduced Malignancy of Human Breast Cancer Cells Due to Co-Silencing of HER2 and PTK6

Lifetime study in mice for radiation‐induced cataracts

Abstract P2-05-32: Tissue kallikrein-related peptidase 4, a novel biomarker in triple-negative breast cancer

Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells

Chromosomal changes during development and progression of prostate adenocarcinomas

The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer

Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer

The impact of the uPAR system and its interaction partners as potential therapeutic targets in TNBC

PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients

Molecular Genetic Changes in Metastatic Primary Barrett's Adenocarcinoma and Related Lymph Node Metastases: Comparison with Nonmetastatic Barrett's Adenocarcinoma

Heterogeneity in breast cancer and the problem of relevance of findings

Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis

P3-03-04: Targeted Modulation of HER Receptor Signaling in Breast Cancer Using miR-21

Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas

Lifetime Study in mice: 24ￂ months follow up after low doses of ionizing radiation with Scheimpflug imaging and OCT

Suchergebnisse filtern